Marimed (MRMD) Director Edward Gildea Receives 192,308-Share Award

What Happened Edward J. Gildea, a director of Marimed Inc. (MRMD), was granted 192,308 restricted stock units (RSUs) on July 15, 2026 as payment for a portion of his board fees. The RSUs vested upon grant and converted one-for-one into 192,308 shares of common stock at $0.00 per share (compensation, no cash paid). The Form 4 shows the derivative award and the subsequent conversion/settlement; there is no open-market sale of the resulting shares reported.

Key Details

• Transaction date: July 15, 2026 (filed July 17, 2026)
• Award: 192,308 RSUs granted and vested upon grant (footnote F2)
• Conversion: RSUs converted one-for-one into 192,308 common shares (footnote F1)
• Price: $0.00 per share (awarded as compensation; no cash paid)
• Shares owned after transaction: Not specified in the Form 4
• Notable footnotes: F1 — RSUs convert to common stock one-for-one. F2 — RSUs granted and vested on July 15, 2026; no RSUs remain outstanding under this award.
• Filing timeliness: Filed two days after the transaction date (appears timely)

Context This was a compensation award (RSUs paid in lieu of cash fees for board service), not an open-market purchase or sale. Such grants are routine for director compensation and do not, by themselves, signal a buy/sell decision by the insider. The derivative entries reflect the grant and settlement of the RSUs into common shares rather than an exercise of options for cash.